3 Trends Driving Demand for Audience Quality and Scale

Health audience segments help pharma marketers reach high-quality audiences while using media and budget more efficiently. In just the past two years, the implementation of these audience segments has doubled across life sciences advertising campaigns, increasing from 15% to 30%.1

While most campaigns incorporate a reach segment to achieve awareness at scale, the use of premium audience segments continues to rise. Connecting with patients at specific points in their journey, at scale, and across channels enables pharma marketers to be more strategic and agile in their campaigns. With this shift, marketers need to know three trends to stay competitive.

1. Multiple Audience Segments Within One Brand Campaign

Data shows that four out of five campaigns use more than one type of audience segment.2 “We are trying to find patients at different stages in their journey, and in order to do that we need different data sources and different targeting methodologies,” says Anna Cammisa, Director of Business Insights at CMI Media Group. A single campaign could target a patient who has just been diagnosed and is researching disease symptoms, as well as someone who is already undergoing treatment. Applying multiple audience segments gives marketers the flexibility to design one campaign that can achieve multiple goals.

2. Customized Messaging for Different Points of the Patient Journey

Meeting patients at a precise point of their journey requires brands to engage with consumers on their terms. While a broadcast message still has its place, marketers are moving away from a one-size-fits-all approach. Instead, they are focusing on formulating distinct messaging for niche audiences. Using health audience segments makes it easier to find and connect with very specific groups of patients and provides the opportunity to deliver customized messaging where it resonates best.

3. Unified Audience Strategy Across Channels

The media landscape continues to become more fragmented with the introduction and accelerated adoption of technologies such as streaming video, online video, and digital audio. As the way consumers digest content becomes more diverse, marketers have responded by expanding their advertising channels. This has been a necessary route, but often not the most cost-effective or efficient one.

With the increased use of health audience segments, we’re seeing marketers take an audience-first approach to their media strategy. By utilizing the same audience segments across traditional and emerging media channels, brands can engage consumers with the right frequency across platforms and devices.

Marketers can be more efficient in delivering a two-fold campaign—one with both a broader message and then subsequent messages at each step of the patient journey—by working with a single vendor who offers both reach and premium audience segments. When choosing a partner, make sure they can scale up or down depending on campaign goals and work across multiple channels and platforms. And, as with any precise audience targeting, make sure the vendor uses a methodology that supports and respects patient privacy.

  • Sarah Caldwell

    Sarah Caldwell is General Manager, Crossix Analytics at Veeva. Sarah is responsible for Crossix measurement and optimization and audience targeting solutions at Veeva Systems. Crossix leverages connected health data to help life sciences more effectively activate, measure, and optimize their marketing investments. Sarah joined Crossix in 2007 and has consulted with pharmaceutical brands across various therapeutic areas and business situations, including launch and loss of exclusivity.

  • Jeremy Mittler

    Jeremy Mittler is Head of Crossix Audience Segments at Veeva. Jeremy joined Crossix in 2008 and has more than 20 years of pharmaceutical and healthcare analytics and consulting experience. Prior to joining Crossix in 2008, Jeremy worked with many of the top pharmaceutical companies in leadership roles at Synygy and Campbell Alliance. He holds a BA in economics from the University of Rochester and an MBA from New York University Stern School of Business.

Ads

You May Also Like

The Reality of Connected Medical Devices

Every healthcare facility has been quickly adding large numbers of connected medical devices to ...

ELITE 2023 Data Miner Lindsey Lofgren of Veeva Systems

Lindsey Lofgren Vice President, Product & Data, Veeva Compass Veeva Systems Faster, More Flexible ...

PM360 2023 Trailblazer Awards Brand of the Year Winner DUPIXENT® (dupilumab) Injection

DUPIXENT® (dupilumab) Injection Regeneron & Sanofi and Arnold NYC Since 2017, DUPIXENT, a biologic ...